Denosumab treatment of inoperable or locally advanced giant cell tumor of bone. - Wikidata - awgldk - TriplyDB

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

http://www.wikidata.org/entity/Q37581613

about

Giant cell tumour of the distal radius/ulna: response to pre-operative treatment with short-term denosumab.Nucleoside diphosphate kinase B promotes osteosarcoma proliferation through c-Myc.Left orbital roof giant cell tumor of bone: A case report.

P2860

Q47098512-225DDE96-2FDE-4535-9602-67B6F2CEE812 Q54116955-38E00215-517B-4D75-AA70-25374A760ABD Q55714934-3B5DB0C2-DD5C-4DBE-A26E-2D4330DA2BDD

P2860

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

http://www.wikidata.org/entity/Q37581613

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@en

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@nl

type

label

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@en

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@nl

prefLabel

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@en

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@nl

P1433

Q37581613-8AA206DD-3E4A-4328-81DF-CAE5F37930A2

P1476

Q37581613-E0D34AF0-91F5-48BB-9A7E-3DD526A48942

P2093

Q37581613-0B4D7330-23E0-46B4-894C-3BC701132DFC

Q37581613-2D402515-31BA-4356-BA20-4FF39DC52C44

Q37581613-567B59B3-9C7A-4405-A5EE-1ABABC18CD85

Q37581613-92CD0D7E-D79B-4D3A-998E-5D22513D2672

Q37581613-B9FAE79A-1DFF-4CCB-A350-1CBDE1C979DC

Q37581613-EE716BD0-09F0-461D-A4F0-F199444840F3

Q37581613-F7AE673B-48D1-439C-9BB5-0EA8862C4A79

P2860

Q37581613-00BE3A28-D03E-4E6D-BE0D-E8EF79029797

Q37581613-0388E53B-444A-4A0D-86D7-86F305C4FA20

Q37581613-144895CB-36FD-46E3-86BD-75084E504DC7

Q37581613-2A6354FC-A2EB-4898-B289-9C0908BE5B7E

Q37581613-2E5F6258-5C9C-4F6A-9CFF-95A0B8752024

Q37581613-36F642D2-84C3-4368-9DF0-B896B2636008

Q37581613-4237B14D-88E0-4D48-BF84-AB6AC9C8F38F

Q37581613-4691F0E5-C936-4F96-8C86-96E9F92D4875

Q37581613-4BE32948-F123-4764-A70E-761FD356D5FC

Q37581613-4FC3FC62-81BA-4959-9E67-592CA8C65EB0

P304

Q37581613-7A0B0F61-ECFB-4739-B50B-BFB03874D68E

P31

Q37581613-C7C9DEC1-5DE6-46E2-8AC2-553D2BCE984F

P356

Q37581613-43BDD998-7DCF-4F75-94A5-D2420CDBC2C3

P433

Q37581613-949700CB-6D3A-4D49-ABE9-CE0453B52ACF

P478

Q37581613-1B4E488E-4D53-4D16-B0FF-3B47E5CB531B

P50

Q37581613-635DE071-D0E9-4B68-8A21-F00A1FDBD6BC

P577

Q37581613-E647E12A-6385-4EE6-804A-B15A078DF86B

P698

Q37581613-8C48DB81-0D8F-47D1-B19C-F14CA14C9D13

P932

Q37581613-BF339A6B-CE27-47B0-9829-B18197BC077B

P356

P1433

Oncology Letters

P1476

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.

@en

P2093

Andrzej Pieńkowski

http://www.w3.org/2001/XMLSchema#string

Aneta Borkowska

http://www.w3.org/2001/XMLSchema#string

Ewelina Jagiełło-Wieczorek

http://www.w3.org/2001/XMLSchema#string

Michał Wągrodzki

http://www.w3.org/2001/XMLSchema#string

Milena Szacht

http://www.w3.org/2001/XMLSchema#string

Paweł Rogala

http://www.w3.org/2001/XMLSchema#string

Tomasz Goryń

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

The clinical approach toward giant cell tumor of bone

Updates in the treatment of bone cancer.

Late complications and survival of endoprosthetic reconstruction after resection of bone tumors.

Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy

Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB

Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution.

Giant cell tumour of bone: new treatments in development.

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.

Impending fractures in giant cell tumours of the distal femur: incidence and outcome.

P304

4312-4318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5246

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Rutkowski

P577

2016-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28101196

http://www.w3.org/2001/XMLSchema#string

P932

5228072

http://www.w3.org/2001/XMLSchema#string